Therapeutic Efficacy: A Prerequisite for Novel Intermediates- Delhi High Court ruling in Zeria Pharmaceutical Co. Ltd. v. the Controller of Patents

The Delhi High Court dismissed Zeria Pharmaceutical Co. Ltd.’s (the ‘Appellant’) appeal against the Controller of Patents' (the ‘Respondent’) refusal order of a divisional patent application (3630/DLNP/2011). The ruling focused on a novel intermediate compound rejected for lack of inventive step and for failing to demonstrate enhanced therapeutic efficacy. Case Background  Zeria filed a divisional […]

India- High Court remands matter back to the Patent Office owing to lacunae in assessment of inventive step

The Madras High Court, in a ruling concerning an appeal filed by Hendrickson USA (producers of heavy-duty suspension systems), remanded their patent application for an invention entitled the "Axle Mount for Heavy-Duty Vehicle Brake System Components", back to the Patent Office. The Court determined that the Patent Office had not sufficiently evaluated the "technical advancement" […]